drugset / Trial / NCT02401295
ATRA, Celecoxib, and Itraconazole as Maintenance
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability associated with the combination of ATRA/celecoxib/itraconazole as maintenance therapy given after an autologous stem cell transplant in relapsed multiple myeloma patients.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-08
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 400 mg | Oral |
| Subject | Itraconazole | Small molecule | 200 mg | Oral |
| Subject | Tretinoin | Small molecule | 20 mg | Oral |